Results of penetrating keratoplasty in the iridocorneal endothelial syndrome.
Five patients (four men and one woman ranging in age from 30 to 41 years) with the iridocorneal endothelial syndrome (four with Chandler's syndrome and one with essential iris atrophy) underwent penetrating keratoplasty for complaints relating to diminished visual acuity or pain. After follow-up periods ranging from one year to four years and seven months (average, 2.7 years), postoperative visual acuities ranged from 20/15 to 20/30. No evidence of recurrence of the corneal abnormalities observed before grafting was apparent in the donor corneas at the last examinations. Two patients who required medical treatment for intraocular pressure control preoperatively also required adjuvant therapy postoperatively. These results suggested that penetrating keratoplasty is a relatively safe and effective procedure for patients with diminished vision or other complaints related to corneal abnormalities in the iridocorneal endothelial syndrome. It does not, however, restore to normal the iris and angle structures affected adversely by the progression of the corneal endotheliopathy and therefore other measures may be required to control intraocular pressure.
D000328:Adult; D001284:Atrophy; D003316:Corneal Diseases / Q000601:surgery*; D016039:Corneal Transplantation; D004727:Endothelium; D005260:Female; D006801:Humans; D007499:Iris Diseases / Q000601:surgery*; D008297:Male; D009506:Nevus / Q000601:surgery*; D011680:Pupil; D013577:Syndrome; D014604:Uveal Neoplasms / Q000601:surgery*; D014792:Visual Acuity